Skip to main content

Day: August 19, 2021

Vigil Reports Profitable First Quarter

VICTORIA, British Columbia, Aug. 18, 2021 (GLOBE NEWSWIRE) — Vigil Health Solutions Inc. (“Vigil”) announces the results of operations for the quarter ending June 30, 2021. Developments in the QuarterRevenue of $1.70 million up 36% from $1.25 million in the three month period ended June 30, 2020.Earnings before income taxes were $281 thousand up 64% from $172 thousand in the three month period ended June 30, 2020.Sales bookings for the quarter were $1.71 million up 41% from $1.21 million in the three month period ended June 30, 2020.Adjusted EBITDA of $320 thousand up 43% from $224 thousand in the three months ended June 30, 2020.“We were pleased to see strong sales bookings and revenue in the quarter. We saw the completion of several projects signed in 2019 and early 2020 that were delayed due to the pandemic. While...

Continue reading

Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone – – Data support the use of toripalimab with chemotherapy as first-line therapy for patients with NSCLC – – Study to be presented September 13 at IASLC 2021 World Conference on Lung Cancer – SHANGHAI, China, and REDWOOD CITY, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) —  Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced positive interim results from the pivotal study “CHOICE-01” (NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy as first-line treatment of advanced squamous or non-squamous non-small cell lung...

Continue reading

Eve & Co. Announces Revenues of $4.0M in the First Half of 2021 and Financial Results for the Six Months Ended June 30, 2021

STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF), through its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) is pleased to announce that it has made gross revenues of $4.0 million in the first six months of 2021, successfully surpassing its gross revenues of $3.8 million for the entire 2020 financial year. The Company is also pleased to announce its financial results for the six months ended June 30, 2021 and wishes to highlight the following items;During the first half of 2021, the Company completed additional shipments of EU-GMP certified cannabis to its German customers; On February 11, 2021, the Company announced that it had successfully completed its first shipment of cannabis products to New Brunswick. Its cannabis...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.